Fredun Pharmaceuticals Limited (FREDUN) Share Price

BSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE194R01017

₹1,477.05-13.10 (-0.88%)

Key metrics

Market Cap
₹2,443 Cr
P/E Ratio
63.94
EPS
23.1
Book Value
171.53
P/B Ratio
8.61
ROE
11.58%
ROCE
17.98%
Debt / Equity
0.86
Net Margin
5.15%
Revenue Growth
40.21%
Profit Growth
65.26%
Dividend Yield
0.02%
52W High
₹1,599.90
52W Low
₹383.67
Market Cap Band
small cap
Face Value

Ratios computed from the annual results period ending 2026-03-31.

About Fredun Pharmaceuticals Limited

Fredun Pharmaceuticals Limited manufactures and sells pharmaceutical formulations, dietary/herbal supplements, nutraceuticals, animal healthcare products, cosmeceuticals, mobility and rehabilitation products, and other healthcare products in India, Africa, Southeast Asia, Commonwealth of Independent States countries, MENA region, and Latin America. The company offers allopathic formulations, including analgesics/NSAID, antacid/antiulcer, anthelmintic, antibacterial, anti-diabetic, anti-inflammatory, anti-malarial, anti-obesity, antacid, anthelmintic, anticoagulants, anticonvulsants, antidiarrhoeal, antidepressant, antifungal, antihistamines/antiallergic, antihypertensives, antiviral, bone modulating drugs, bronchodilators and anti-asthma drugs, calcium tablets, cardiovascular, diuretic, impotence drugs, laxative, and appetite stimulant with multivitamins. It also provides surgical products, such as IV fluids and cannulas, disposable syringes, infusion sets, surgical gloves and cottons, and personal healthcare products; APIs; direct compressible granules; pellets; animal healthcare products; aqua products; and niche products. Additionally, the company offers therapeutic products under the brand Hormone Range Products, a specialty therapeutics brand focused on longevity, hormone health, recovery science, and human performance solutions. Fredun Pharmaceuticals Limited was incorporated in 1987 and is headquartered in Mumbai, India.,

Headquarters
Mumbai, India
Employees
736
Promoter Holding
55.06%

The full Fredun Pharmaceuticals Limited analysis

Create a free account to open the complete FREDUN deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.

  • 10-year financialsIncome statement, balance sheet and cash flow, year by year.
  • Valuation & fair valueFair-value estimates, quality scores and a value grade.
  • Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
  • Shareholding historyPromoter, FII, DII and public holdings across every quarter.
  • Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
  • Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.